EcoDrugPlus

Tubulin, Alpha 4a

Ensembl ID : ENSMSIG00000018170
Gene Symbol: TUBA4A
1 Cross references
239 Possible Orthologues:

Tubulin, Beta 1 Class Vi

Ensembl ID : ENSMSIG00000027325
Gene Symbol: TUBB1
1 Cross references
201 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSMSIG00000003218
Gene Symbol: TUBB2A
1 Cross references
193 Possible Orthologues:

Tubulin, Beta 3 Class Iii

Ensembl ID : ENSMSIG00000013934
Gene Symbol: TUBB3
1 Cross references
108 Possible Orthologues:

Tubulin, Beta 4a Class Iva

Ensembl ID : ENSMSIG00000021731
Gene Symbol: TUBB4A
1 Cross references
109 Possible Orthologues:

Tubulin, Beta 4b Class Ivb

Ensembl ID : ENSMSIG00000023582
Gene Symbol: TUBB4B
1 Cross references
328 Possible Orthologues:

Tubulin, Beta 5 Class I

Ensembl ID : ENSMSIG00000015128
Gene Symbol: TUBB5
1 Cross references
87 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSMSIG00000020317
Gene Symbol: TUBB6
1 Cross references
156 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSMSIG00000001626
Gene Symbol: TYR
1 Cross references
281 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSMSIG00000028344
Gene Symbol: TH
1 Cross references
202 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSMSIG00000016941
Gene Symbol: TYK2
1 Cross references
211 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin-Like And Egf-Like Domains 1

Ensembl ID : ENSMSIG00000016295
Gene Symbol: TIE1
1 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).